Stay updated with breaking news from Keith Aqua. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- The largest-scale consumer safety study to date shows orally ingested cannabidiol (CBD) is safe for daily consumption. Results from a...
Validcare Announces a Second Cohort of CBD Brands Joins Safety Study to Gather Data for FDA Share Article Validcare's Decentralized Clinical Trial Allows for Consumer Participation During COVID "We are excited to have our state of the art, decentralized trial technology overcome the hurdles of performing research during a pandemic." DENVER (PRWEB) April 15, 2021 Validcare announced today the addition of a second cohort of CBD brands participating in a large scale, human safety study, a significant and widescale endeavor to answe...
:strip_exif(true):strip_icc(true):no_upscale(true):quality(65)/cloudfront-us-east-1.images.arcpublishing.com/gmg/3SLBLFOA5BGX5AZEUZHBXQYLNI.jpg)
Study: No evidence of liver toxicity from use of CBD from hemp Investigators report to FDA no evidence of liver toxicity in 839 adults consuming oral CBD Published: Updated: Tags: CBD products Researchers presented initial results from a study to the FDA in March suggesting there is no evidence of liver disease from the use of hemp-derived CBD products. The study, conducted by a team from clinical research company Validcare, aims to help the FDA to determine how to appropriately regulate CBD products. CBD, short for cannabidiol, comes from the cannabis plant. It is one of two most com...